Christopher M. Kramer

1994–2025 年に発表

153
論文数
30,575
被引用数
88
h 指数
144
i10 指数

被引用数

Christopher M. Kramer の年別被引用数1995 年: 被引用 4 件1996 年: 被引用 3 件1997 年: 被引用 5 件1998 年: 被引用 14 件1999 年: 被引用 25 件2000 年: 被引用 24 件2001 年: 被引用 20 件2002 年: 被引用 19 件2003 年: 被引用 36 件2004 年: 被引用 46 件2005 年: 被引用 34 件2006 年: 被引用 32 件2007 年: 被引用 72 件2008 年: 被引用 81 件2009 年: 被引用 97 件2010 年: 被引用 105 件2011 年: 被引用 139 件2012 年: 被引用 134 件2013 年: 被引用 162 件2014 年: 被引用 157 件2015 年: 被引用 136 件2016 年: 被引用 172 件2017 年: 被引用 173 件2018 年: 被引用 176 件2019 年: 被引用 565 件2020 年: 被引用 783 件2021 年: 被引用 1,038 件2022 年: 被引用 842 件2023 年: 被引用 713 件2024 年: 被引用 1,344 件2025 年: 被引用 907 件2026 年: 被引用 47 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,936 件、この内訳の 23.6%イギリス: 引用元論文 1,294 件、この内訳の 10.4%イタリア: 引用元論文 894 件、この内訳の 7.2%ドイツ: 引用元論文 878 件、この内訳の 7.1%中国: 引用元論文 681 件、この内訳の 5.5%オランダ: 引用元論文 557 件、この内訳の 4.5%カナダ: 引用元論文 531 件、この内訳の 4.3%フランス: 引用元論文 374 件、この内訳の 3%スペイン: 引用元論文 340 件、この内訳の 2.7%オーストラリア: 引用元論文 307 件、この内訳の 2.5%スイス: 引用元論文 295 件、この内訳の 2.4%日本: 引用元論文 246 件、この内訳の 2%
0%23.6%その他 24.8%

分野

  • Medicine87.4%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Engineering2.2%
  • Neuroscience1.3%
  • Computer Science1.2%
  • Immunology and Microbiology0.9%
  • その他2.2%

トピック

  • Cardiac Imaging and Diagnostics11.6%
  • Cardiovascular Function and Risk Factors8.4%
  • Cardiomyopathy and Myosin Studies5.1%
  • Advanced MRI Techniques and Applications4.8%
  • Viral Infections and Immunology Research2.8%
  • Cardiovascular Effects of Exercise2.7%
  • その他64.6%

共著者

全論文

検索で開く
  1. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gilbert R. Upchurch, Aaron W. Aday, Ali Azizzadeh, Michael L. Boisen, Beau Hawkins, Christopher M. Kramer, Jessica G.Y. Luc, Thomas E. MacGillivray, S. Chris Malaisrie, Kathryn Osteen, Himanshu J. Patel, Parag J. Patel, Wanda M. Popescu, Evelio Rodríguez, Rebecca Sorber, Philip S. Tsao, Annabelle Santos Volgman - Circulation 2022 被引用: 1,841

  2. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 783

  3. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emeline M. Van Craenenbroeck, Miloš Kubánek, David Zemánek, Morten K. Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagège, Olivier Lairez, Jean‐Noël Trochu, Christoph Axthelm, H DUENGEN, Norbert Frey, Veselin Mitrović, Michael R. Preusch, Jeanette Schulz‐Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna R. Zwas, Iacopo Olivotto, Hans‐Peter Brunner‐La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko‐Sarnowska, Artur Oręziak, Wojciech Wojakowski, Nuno Cardim, Helder Pereira, Roberto Barriales‐Villa, Pablo García Pavía, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore P. Abraham, Kia Afshar, Paulino Álvarez, Richard G. Bach, Richard C. Becker, Lubna Choudhury, David Fermin, Daniel Jacoby, John L. Jefferies, Christopher M. Kramer, Neal K. Lakdawala, Steven J. Lester, Ali J. Marian, Ahmad Masri, Matthew J. Maurer, Sherif F. Nagueh, Anjali Owens, David S. Owens, Florian Rader, Sara Saberi, Mark V. Sherrid, Jamshid Shirani, John D. Symanski, Aslan T. Turer, Andrew Wang, Omar Wever‐Pinzon, Matthew T. Wheeler, Timothy C. Wong, Mohamad H. Yamani - The Lancet 2020 被引用: 1,210

  4. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 1,970

  5. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update

    著者: , , , , , - Journal of Cardiovascular Magnetic Resonance 2020 被引用: 1,197

  6. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update

    著者: , , , , , , , , , , , - Journal of Cardiovascular Magnetic Resonance 2020 被引用: 972

  7. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing

    著者: , , , , , , , , , , , - Journal of Cardiovascular Magnetic Resonance 2013 被引用: 1,515

  8. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 被引用: 193

  9. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lubna Choudhury, Andrew Crean, Dana Dawson, Milind Y. Desai, Eleanor Elstein, Andrew Flett, Matthias G. Friedrich, Stephen B. Heitner, Adam Helms, Daniel Jacoby, Han Kim, Bette Kim, Éric Larose, Masliza Mahmod, Heiko Mahrholdt, Martin S. Maron, Gerry P McCann, Michelle Michels, Saidi Mohiddin, Sherif F. Nagueh, David E. Newby, Iacopo Olivotto, Anjali Owens, François Pierre-Mongeon, Sanjay Prasad, Ornella Rimoldi, Michael Salerno, Jeanette Schulz‐Menger, Mark V. Sherrid, Peter Swoboda, Albert C. van Rossum, Jonathan W. Weinsaft, James A. White, Eric E. Williamson, Rafik Tadros, James S. Ware, Connie R. Bezzina, Martin Farrall, Hugh Watkins - Nature Genetics 2021 被引用: 339

  10. Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Bradlow, Michael Salerno, Stephen B. Heitner, Sanjay Prasad, Saidi Mohiddin, Peter Swoboda, Heiko Mahrholdt, Chiara Bucciarelli‐Ducci, Jonathan W. Weinsaft, Han Kim, Gerry P McCann, Albert C. van Rossum, Eric E. Williamson, Andrew Flett, Dana Dawson, François‐Pierre Mongeon, Iacopo Olivotto, Andrew Crean, Anjali Owens, Lisa Anderson, Elena Biagini, David E. Newby, Colin Berry, Bette Kim, Éric Larose, Theodore P. Abraham, Mark V. Sherrid, Sherif F. Nagueh, Ornella Rimoldi, Eleanor Elstein, Camillo Autore - Journal of the American College of Cardiology 2019 被引用: 321

  11. Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2020 被引用: 235

  12. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2024 被引用: 142

  13. Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 351

  14. Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology

    著者: , , , , , , , , , , , , , , - American Journal of Preventive Cardiology 2022 被引用: 99

  15. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 被引用: 114

  16. Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

    著者: , , , , , , , , , - Nature Medicine 2024 被引用: 118

  17. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2021 被引用: 124

  18. Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging

    著者: , , , , , - Journal of the American College of Cardiology 2021 被引用: 133

  19. Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy

    著者: , , , , , - Circulation Cardiovascular Imaging 2013 被引用: 377

  20. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy

    著者: , - JACC. Cardiovascular imaging 2017 被引用: 309

  21. Criteria for Evaluation of Novel Markers of Cardiovascular Risk

    著者: , , , , , , , , , , , , , , , , , - Circulation 2009 被引用: 1,133

  22. Coronary Microvascular Dysfunction, Microvascular Angina, and Treatment Strategies

    著者: , , , , , - JACC. Cardiovascular imaging 2015 被引用: 301

  23. Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction

    著者: , , , , , , , , , - JACC. Cardiovascular imaging 2021 被引用: 101

  24. Society for Cardiovascular Magnetic Resonance (SCMR) guidelines for reporting cardiovascular magnetic resonance examinations

    著者: , , , , , , , , , , , , , , , , , - Journal of Cardiovascular Magnetic Resonance 2022 被引用: 86